Over the last 7 days, the Pharma industry has dropped 1.4%, driven by a pullback from AFT Pharmaceuticals of 2.8%. On the other hand Rua Bioscience is actually up 10%. Overall the industry is down 13% in 12 months. Earnings are forecast to grow by 24% annually.
Has the New Zealand Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Mon, 27 Mar 2023 | NZ$481.6m | NZ$150.7m | NZ$1.1m | 21.2x | 440.4x | 3.2x |
Wed, 22 Feb 2023 | NZ$497.7m | NZ$153.3m | NZ$1.2m | 21.8x | 411.7x | 3.2x |
Fri, 20 Jan 2023 | NZ$522.1m | NZ$153.3m | NZ$1.2m | 23.4x | 431.9x | 3.4x |
Sun, 18 Dec 2022 | NZ$502.4m | NZ$153.3m | NZ$1.2m | 22.3x | 415.6x | 3.3x |
Tue, 15 Nov 2022 | NZ$505.8m | NZ$143.0m | NZ$3.9m | 19.3x | 130x | 3.5x |
Thu, 13 Oct 2022 | NZ$490.8m | NZ$143.0m | NZ$3.9m | 17.9x | 126.1x | 3.4x |
Sat, 10 Sep 2022 | NZ$512.6m | NZ$142.3m | NZ$8.0m | 18.5x | 64.3x | 3.6x |
Mon, 08 Aug 2022 | NZ$537.9m | NZ$141.0m | NZ$9.7m | 19.1x | 55.4x | 3.8x |
Wed, 06 Jul 2022 | NZ$525.7m | NZ$141.0m | NZ$9.7m | 18.8x | 54.1x | 3.7x |
Fri, 03 Jun 2022 | NZ$594.1m | NZ$140.7m | NZ$10.1m | 22.4x | 58.7x | 4.2x |
Sun, 01 May 2022 | NZ$543.3m | NZ$130.2m | NZ$920.3k | 35.4x | 590.3x | 4.2x |
Tue, 29 Mar 2022 | NZ$540.4m | NZ$130.2m | NZ$2.2m | 34.8x | 248.2x | 4.2x |
Thu, 24 Feb 2022 | NZ$592.5m | NZ$129.0m | -NZ$95,598.00 | n/a | -6197.9x | 4.6x |
Sat, 22 Jan 2022 | NZ$647.6m | NZ$129.0m | -NZ$95,598.00 | n/a | -6774.2x | 5x |
Mon, 20 Dec 2021 | NZ$636.2m | NZ$129.0m | -NZ$95,598.00 | 41.3x | -6655x | 4.9x |
Wed, 17 Nov 2021 | NZ$701.5m | NZ$124.1m | -NZ$281,598.00 | n/a | -2491.1x | 5.7x |
Fri, 15 Oct 2021 | NZ$617.7m | NZ$124.1m | -NZ$281,598.00 | 96.4x | -2193.7x | 5x |
Sun, 12 Sep 2021 | NZ$645.5m | NZ$124.1m | -NZ$281,598.00 | 103x | -2292.2x | 5.2x |
Tue, 10 Aug 2021 | NZ$666.3m | NZ$124.7m | -NZ$281,598.00 | 108.4x | -2366.2x | 5.3x |
Mon, 03 May 2021 | NZ$664.2m | NZ$124.7m | NZ$307.1k | 91.1x | 2162.7x | 5.3x |
Thu, 04 Feb 2021 | NZ$770.9m | NZ$122.2m | -NZ$823,103.00 | 86.9x | -936.5x | 6.3x |
Sun, 08 Nov 2020 | NZ$786.4m | NZ$119.7m | -NZ$1,636,586.00 | 111.7x | -480.5x | 6.6x |
Sat, 01 Aug 2020 | NZ$628.9m | NZ$117.8m | NZ$6.3m | 57.1x | 100.1x | 5.3x |
Tue, 05 May 2020 | NZ$549.1m | NZ$116.5m | NZ$10.8m | 45.4x | 50.8x | 4.7x |
42.7x
Which industries have driven the changes within the New Zealand Healthcare industry?
NZ Market | -1.14% | |
Healthcare | 0.96% | |
Pharma | -1.42% | |
Pharma | -1.42% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
RUA Rua Bioscience | NZ$0.20 | 10.5% +NZ$3.0m | -51.2% | PS60.1x | |
CBD Cannasouth | NZ$0.29 | 5.4% +NZ$2.2m | -4.8% | PS310.3x | |
GFI Greenfern Industries | NZ$0.092 | 1.1% +NZ$109.9k | -42.5% | n/a |